Letters
Coronary artery disease: screen or treat?
Ignoring adverse experiences of people taking statins
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2030 (Published 12 April 2016) Cite this as: BMJ 2016;353:i2030
- Thomas L Perry, physician
- Department of Medicine, UBC Hospital, Vancouver, Canada V6T 2B5
- tom.perry{at}ti.ubc.ca
In primary prevention trials statins slightly reduce atherosclerotic events but not total serious adverse events.1 Another paradox is that many patients have muscle pain, fatigue, or weakness that resolves when they stop the drug, yet clinical trialists do not believe in a causal association.
Francis and Cole assert that statins cause no more …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.